Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stemden is a pre-clinical stage biotechnology company focused on developing regenerative therapies for hair loss and skin disorders. Founded by experts in stem cell biology from the University of Southern California, the company utilizes a proprietary platform to identify small molecules that activate quiescent hair follicle stem cells. Their lead programs target androgenetic alopecia and other forms of hair loss by restoring the natural hair growth cycle. In addition to hair regrowth, Stemden is exploring applications in chronic wound healing and skin rejuvenation. The company's approach aims to provide non-invasive and effective treatments for conditions with significant unmet medical needs in dermatology. Stemden's research is rooted in decades of academic study into the mechanisms of skin and appendage regeneration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stemden.